Clinical Trials: Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Click here to access this third-party resource:

Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis

Study Type: Interventional

Age/Gender Requirements: 1 year+ (male/female)

Sponsor: Bausch & Lomb, Inc.

Purpose: This study will evaluate “the clinical and microbial efficacy of besifloxacin ophthalmic suspension compared with vehicle” for the treatment of bacterial conjunctivitis.